Differential mechanisms of CDKN2A (p16) alteration in oral tongue squamous cell carcinomas and correlation with patient outcome. - Wikidata - awgldk - TriplyDB

Differential mechanisms of CDKN2A (p16) alteration in oral tongue squamous cell carcinomas and correlation with patient outcome.

Differential mechanisms of CDKN2A (p16) alteration in oral tongue squamous cell carcinomas and correlation with patient outcome.

http://www.wikidata.org/entity/Q54383855

about

Loss of CDKN2A expression is a frequent event in primary invasive melanoma and correlates with sensitivity to the CDK4/6 inhibitor PD0332991 in melanoma cell lines.p16 protein expression and human papillomavirus status as prognostic biomarkers of nonoropharyngeal head and neck squamous cell carcinoma Frequency and prognostic significance of p16(INK4A) protein overexpression and transcriptionally active human papillomavirus infection in laryngeal squamous cell carcinoma.Quantitative methodology is critical for assessing DNA methylation and impacts on correlation with patient outcome Association between P16INK4a promoter methylation and HNSCC: a meta-analysis of 21 published studies.The CDK4/6 inhibitor LY2835219 has potent activity in combination with mTOR inhibitor in head and neck squamous cell carcinoma Genome-scale methylation assessment did not identify prognostic biomarkers in oral tongue carcinomas Oral Cavity Carcinoma: Current Management, Controversies, and Future Directions.Prognostic biomarkers for oral tongue squamous cell carcinoma: a systematic review and meta-analysis.The role of human papillomavirus in p16 positive oral cancers.PRISM: Phase 2 trial with panitumumab monotherapy as second-line treatment in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.Human papillomavirus and p16 protein expression as prognostic biomarkers in mobile tongue cancer.The role of protein p16 in non-oropharyngeal head and neck squamous cell carcinoma in Southern China

P2860

Q27852814-8AB8924D-F7E8-4381-B417-D515A213AF1D Q27853077-4E412ACA-221A-4B6C-9C9E-2FD325A7149F Q35198357-8DD4CB78-2D4C-4012-86FB-FDEA368F35A7 Q35341665-75688118-967D-40C4-98BD-5DAEDFF9BF83 Q35593076-9ED3478E-2C35-4E5C-BA2D-8223BE4E4C14 Q37046726-47BA2D9E-5DD9-4F79-8D7F-5DC874E1802C Q37101724-88BFB49F-5C56-4FC8-ADA2-09800E74AE64 Q37658802-1D4C5B34-1D20-44A8-9530-A59C2276DDE3 Q40104856-6180ACFF-D8AC-4FC8-90CA-6CB2F7CAF1A6 Q41918104-C6D7127C-2F28-4091-85C4-448FBD610427 Q46500151-D0DCE2E3-06FB-4157-BCC8-5192B0BD3BC6 Q47723245-2F4E7374-FC1D-4248-B2D0-7F84589C65D4 Q58573257-29C2501E-6751-4DAD-8AB6-F549F74ADACC

P2860

Differential mechanisms of CDKN2A (p16) alteration in oral tongue squamous cell carcinomas and correlation with patient outcome.

http://www.wikidata.org/entity/Q54383855

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Differential mechanisms of CDK ...... relation with patient outcome.

@en

Differential mechanisms of CDKN2A

@nl

type

label

Differential mechanisms of CDK ...... relation with patient outcome.

@en

Differential mechanisms of CDKN2A

@nl

prefLabel

Differential mechanisms of CDK ...... relation with patient outcome.

@en

Differential mechanisms of CDKN2A

@nl

P1433

Q54383855-A13AD55B-060B-4667-B62D-11CDF6810379

P1476

Q54383855-AD35605F-79C3-4B52-BA44-1ADAC998D61C

P2093

Q54383855-309DEA3F-218A-4D4A-8537-01C21BB5E52A

Q54383855-68DEA746-0C38-450F-BC6F-73C1B0C24A3E

Q54383855-725B6CB9-1358-4F37-BC83-9BB4DAAE5048

Q54383855-836F98CB-23A0-4023-981C-71B799D37E77

Q54383855-8A399F64-B6CE-4403-8E3F-C8312BF8A526

Q54383855-95EF3CF9-CD43-467A-901E-D1FAC51DC97B

Q54383855-A8C541E7-FA53-409D-A696-B5A54BD9AD01

Q54383855-BA479374-FC47-4C2C-A0B1-D4FAEC63130E

Q54383855-BAE1AF63-CD95-49A8-8B48-029E76379E07

Q54383855-CCDA4978-85D0-46DB-A285-73DBFEA5FE75

P2860

Q54383855-040EFDEB-0706-4B4B-9B54-656552ABAAA9

Q54383855-0ACC3746-D30B-4C79-9954-70935E246089

Q54383855-0BA3E7CE-823D-4845-B79F-91DE1D038A4F

Q54383855-232D0E28-9D5B-401E-8018-5C31966414B7

Q54383855-2386A9B1-420B-4813-94E6-FE5912854F0D

Q54383855-28997950-A8E5-454F-A739-CE8012E5B043

Q54383855-37FE21A6-354F-4C34-A48A-EC4A5810C842

Q54383855-58C960ED-1FBF-4CA8-919B-47935B11BE2E

Q54383855-5A0DE381-F92F-4F51-9C49-6C5700540B57

Q54383855-71AC9102-6DFE-4DC6-8A55-D63551D25ED6

P304

Q54383855-1D72D213-A430-4C95-A0B9-8BF660292820

P31

Q54383855-F3596DF6-8AAA-4760-B700-2BF7F2FF9355

P356

Q54383855-D2D68542-ACBA-4C07-BAA6-B73832DCE29C

P433

Q54383855-AD6D6440-5DC8-49F4-9791-62B9429BF0A7

P478

Q54383855-5AF8096A-DDF5-4B3F-89FC-D8855C223283

P50

Q54383855-133C2FB0-9E30-489B-BECA-D6159F47F8C0

Q54383855-2D98EA5C-B412-473B-BBD0-F7EDB3875C16

Q54383855-6FAA91BD-B8AE-4B53-A5D0-E38DCFE59047

Q54383855-80FAF366-A78D-4BD5-8BDE-70469CCFCF1E

P577

Q54383855-2E1C3252-4630-486A-A6E0-94551BF62D40

P5875

Q54383855-1C4429A6-8336-4FE7-80A0-8A1B148758EB

P698

Q54383855-BBFEA4FD-4554-42AE-984A-EDA642238469

P356

P1433

International Journal of Cancer

P1476

Differential mechanisms of CDK ...... relation with patient outcome.

@en

P2093

Annette M Lim

http://www.w3.org/2001/XMLSchema#string

Benjamin Solomon

http://www.w3.org/2001/XMLSchema#string

Bernard Lyons

http://www.w3.org/2001/XMLSchema#string

Christopher Angel

http://www.w3.org/2001/XMLSchema#string

Danny Rischin

http://www.w3.org/2001/XMLSchema#string

Elena A Takano

http://www.w3.org/2001/XMLSchema#string

Elizabeth Sigston

http://www.w3.org/2001/XMLSchema#string

Hongdo Do

http://www.w3.org/2001/XMLSchema#string

June Corry

http://www.w3.org/2001/XMLSchema#string

Marnie Collins

http://www.w3.org/2001/XMLSchema#string

P2860

Promoter methylation of P16, RARbeta, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencing

Methylation-sensitive high resolution melting (MS-HRM): a new approach for sensitive and high-throughput assessment of methylation

Promoter methylation and loss of p16(INK4a) gene expression in head and neck cancer

Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1

The mutational landscape of head and neck squamous cell carcinoma

DMSO and betaine greatly improve amplification of GC-rich constructs in de novo synthesis.

Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial.

Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers.

Assessing combined methylation-sensitive high resolution melting and pyrosequencing for the analysis of heterogeneous DNA methylation

Genome-wide methylation and expression differences in HPV(+) and HPV(-) squamous cell carcinoma cell lines are consistent with divergent mechanisms of carcinogenesis.

P304

887-895

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IJC.28727

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

135

http://www.w3.org/2001/XMLSchema#string

P50

Alexander Dobrovic

Stephen Q. Wong

David Wiesenfeld

P577

2014-01-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259771211

http://www.w3.org/2001/XMLSchema#string

P698

24436120

http://www.w3.org/2001/XMLSchema#string